Mengdan Xu

1.5k total citations
65 papers, 1.1k citations indexed

About

Mengdan Xu is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Mengdan Xu has authored 65 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 17 papers in Molecular Biology and 13 papers in Cancer Research. Recurrent topics in Mengdan Xu's work include Inflammatory Biomarkers in Disease Prognosis (10 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Cancer, Lipids, and Metabolism (5 papers). Mengdan Xu is often cited by papers focused on Inflammatory Biomarkers in Disease Prognosis (10 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Cancer, Lipids, and Metabolism (5 papers). Mengdan Xu collaborates with scholars based in China, Canada and United States. Mengdan Xu's co-authors include Shenglong Li, Mengyao Wu, Fei‐Ran Gong, Yan Zhang, Meng Shen, Jessica Robin, Min Tao, Min Tao, Min Jiang and Qiaoming Zhi and has published in prestigious journals such as Blood, The American Journal of Gastroenterology and Acta Biomaterialia.

In The Last Decade

Mengdan Xu

61 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengdan Xu China 18 458 281 211 145 142 65 1.1k
Ajaz A. Bhat Qatar 13 714 1.6× 242 0.9× 294 1.4× 148 1.0× 68 0.5× 36 1.2k
Chia‐Lin Liu Taiwan 18 367 0.8× 208 0.7× 147 0.7× 174 1.2× 95 0.7× 32 1.0k
Shahram Taeb Iran 17 309 0.7× 248 0.9× 155 0.7× 195 1.3× 128 0.9× 43 1000
Yen‐Yun Wang Taiwan 22 540 1.2× 294 1.0× 207 1.0× 161 1.1× 200 1.4× 79 1.3k
Olga Sukocheva Australia 26 1.2k 2.7× 261 0.9× 304 1.4× 160 1.1× 171 1.2× 71 2.0k
Tao Gu China 23 673 1.5× 270 1.0× 338 1.6× 341 2.4× 161 1.1× 85 1.4k
Qingfei Chu China 15 856 1.9× 274 1.0× 350 1.7× 226 1.6× 123 0.9× 30 1.5k
Dan Yao China 20 309 0.7× 208 0.7× 82 0.4× 98 0.7× 197 1.4× 65 1.0k
Wei‐Ming Wang China 23 802 1.8× 217 0.8× 183 0.9× 195 1.3× 190 1.3× 140 1.7k

Countries citing papers authored by Mengdan Xu

Since Specialization
Citations

This map shows the geographic impact of Mengdan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengdan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengdan Xu more than expected).

Fields of papers citing papers by Mengdan Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengdan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengdan Xu. The network helps show where Mengdan Xu may publish in the future.

Co-authorship network of co-authors of Mengdan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Mengdan Xu. A scholar is included among the top collaborators of Mengdan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengdan Xu. Mengdan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Kehao, Huijuan Zhu, Mengdan Xu, et al.. (2025). RNF185 promotes esophageal squamous cell carcinoma progression by regulating BAK1 ubiquitination and activating the cGAS–STING–IRF3 pathway. European journal of medical research. 30(1). 1139–1139.
2.
Xu, Mengdan, et al.. (2024). Factors influencing safe use of drugs among community residents: a cross-sectional study. BMC Public Health. 24(1). 2373–2373. 3 indexed citations
3.
Xu, Mengdan, et al.. (2024). Improvement of in vivo iron bioavailability using mung bean peptide-ferrous chelate. Food Research International. 190. 114602–114602. 9 indexed citations
4.
Xu, Mengdan & Shenglong Li. (2023). Nano-drug delivery system targeting tumor microenvironment: A prospective strategy for melanoma treatment. Cancer Letters. 574. 216397–216397. 73 indexed citations
5.
Li, Haili, et al.. (2023). Peptide composition analysis, structural characterization, and prediction of iron binding modes of small molecular weight peptides from mung bean. Food Research International. 175. 113735–113735. 16 indexed citations
6.
Xu, Mengdan, et al.. (2023). Pharmacovigilance for rare diseases: a bibliometrics and knowledge-map analysis based on web of science. Orphanet Journal of Rare Diseases. 18(1). 303–303. 4 indexed citations
7.
DeSouza, Danielle D., et al.. (2023). Evaluating the utility of daily speech assessments for monitoring depression symptoms. Digital Health. 9. 589824235–589824235. 7 indexed citations
8.
9.
Huang, Shi‐Liang, Mengdan Xu, Dan Zhao, et al.. (2023). The association between sleep duration, quality, and nonalcoholic fatty liver disease: A cross-sectional study. Open Medicine. 18(1). 20230670–20230670. 9 indexed citations
10.
Zhang, Jiulong, Xiaoyan Sun, Mengdan Xu, et al.. (2022). A Self-amplifying ROS-sensitive prodrug-based nanodecoy for circumventing immune resistance in chemotherapy-sensitized immunotherapy. Acta Biomaterialia. 149. 307–320. 25 indexed citations
11.
12.
Zou, Dan, Jin Bai, Chunjiao Yang, et al.. (2021). Identification of Novel Drug Candidate for Epithelial Ovarian Cancer via In Silico Investigation and In Vitro Validation. Frontiers in Oncology. 11. 745590–745590. 7 indexed citations
13.
Zhu, Feng, et al.. (2021). Myoglobin and troponin as prognostic factors in patients with COVID-19 pneumonia. Medicina Clínica (English Edition). 157(4). 164–171. 6 indexed citations
14.
Robin, Jessica, Mengdan Xu, Liam D. Kaufman, & William Simpson. (2021). Using Digital Speech Assessments to Detect Early Signs of Cognitive Impairment. Frontiers in Digital Health. 3. 749758–749758. 39 indexed citations
15.
Zhu, Feng, et al.. (2021). Myoglobin and troponin as prognostic factors in patients with COVID-19 pneumonia. Medicina Clínica. 157(4). 164–171. 13 indexed citations
16.
Lu, Yujie, Wen‐Jie Wang, Min Jiang, et al.. (2019). Prognostic values of platelet-associated indicators in advanced breast cancer. Translational Cancer Research. 8(4). 1326–1335. 1 indexed citations
17.
Xu, Mengdan, Lu Liu, Mengyao Wu, et al.. (2018). The combination of cantharidin and antiangiogenic therapeutics presents additive antitumor effects against pancreatic cancer. Oncogenesis. 7(11). 94–94. 28 indexed citations
18.
Wang, Yi, Mengdan Xu, Fei‐Ran Gong, et al.. (2018). The values of applying classification and counts of white blood cells to the prognostic evaluation of resectable gastric cancers. BMC Gastroenterology. 18(1). 99–99. 10 indexed citations
19.
Wu, Xiao Yu, Mengyao Wu, Min Jiang, et al.. (2017). TNF-α sensitizes chemotherapy and radiotherapy against breast cancer cells. Cancer Cell International. 17(1). 13–13. 61 indexed citations
20.
Chao, Jianbin, et al.. (2007). Synthesis of Zn(II)-cloxacillin sodium complex and study of its interaction with calf thymus DNA. Biochemistry (Moscow). 72(2). 153–161. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ajaz A. Bhat Breakdown of academic impact, for papers by Chia‐Lin Liu Breakdown of academic impact, for papers by Shahram Taeb Breakdown of academic impact, for papers by Yen‐Yun Wang Breakdown of academic impact, for papers by Olga Sukocheva Breakdown of academic impact, for papers by Tao Gu Breakdown of academic impact, for papers by Qingfei Chu Breakdown of academic impact, for papers by Dan Yao Breakdown of academic impact, for papers by Wei‐Ming Wang
Rankless by CCL
2026